Premedication with fentanyl or fentanyl and midazolam for endoscopic retrograde cholangiopancreatography
Not Applicable
- Conditions
- Cholelithiasis.Any condition listed in K80.2 with acute cholecystitis
- Registration Number
- IRCT2016031120795N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
patients with ASA class I-III who will undergo endoscopic retrograde cholangiopancreatography(ERCP). Exclusion criteria: Emergency ERCP; Liver or kidney diseases; previous history of sedatives or tranquilizers.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Respiratory effects. Timepoint: Before and instantly after intervention. Method of measurement: Apnea presence.
- Secondary Outcome Measures
Name Time Method Hemodynamic effects. Timepoint: After intervention. Method of measurement: Blood pressure and Heart rate measuring.